Alex B. Chebl (@alexchebl) 's Twitter Profile
Alex B. Chebl

@alexchebl

ID: 3908058552

linkhttp://hfhs.org calendar_today16-10-2015 00:20:26

395 Tweet

299 Followers

61 Following

Thanh Nguyen 🇺🇦 (@nguyenthanhmd) 's Twitter Profile Photo

🗞️Safety & Outcome of Revascularization Treatment in Patients With Acute Stroke & COVID-19: The 🌎Global COVID-19 Stroke Registry 🧠n.neurology.org/content/early/… Outstanding work led by João Pedro Marto, Davide Strambo George Ntaios Patrik Michel CHUV / Centre hospitalier universitaire vaudois with our 🌎 colleagues⬇️

🗞️Safety & Outcome of Revascularization Treatment in Patients With Acute Stroke & COVID-19: The 🌎Global COVID-19 Stroke Registry 🧠n.neurology.org/content/early/… 

Outstanding work led by João Pedro Marto, <a href="/DStrambo/">Davide Strambo</a> <a href="/GeorgeNtaios/">George Ntaios</a> Patrik Michel <a href="/CHUVLausanne/">CHUV / Centre hospitalier universitaire vaudois</a> with our  🌎 colleagues⬇️
Henry Ford Health (@henryfordhealth) 's Twitter Profile Photo

"This is about giving #Detroit what every major U.S. city has and deserves: a world-class academic medical center and campus that will change the face - and the delivery - of care as this community knows it." - Steven N. Kalkanis MD. Details: ow.ly/E5Ui50MMnOW

"This is about giving #Detroit what every major U.S. city has and deserves: a world-class academic medical center and campus that will change the face - and the delivery - of care as this community knows it." 
- <a href="/SteveKalkanisMD/">Steven N. Kalkanis MD</a>. Details: ow.ly/E5Ui50MMnOW
Alex B. Chebl (@alexchebl) 's Twitter Profile Photo

ANGEL-ASPECT RCT of EVT for large core <24hrs: stop early for EFFICACY! Median ASPECTS 3 & inf vol 60-63cc. Benefit all subgroups. sICH 6.1% vs2.7%. No diff in mortality. Less sleep for us, less disability for pts #ISC23 Henry Ford Neuroscience Owais K. Alsrouji Ghada A Mohamed. Hassan Aboul-Nour حسن أبو النور

ANGEL-ASPECT RCT of EVT for large core &lt;24hrs: stop early for EFFICACY! Median ASPECTS 3 &amp; inf vol 60-63cc. Benefit all subgroups. sICH 6.1% vs2.7%. No diff in mortality. Less sleep for us, less disability for pts #ISC23 <a href="/HenryFordNeuro/">Henry Ford Neuroscience</a> <a href="/OwaisAlsrouji/">Owais K. Alsrouji</a> <a href="/GhadaMohamedMD/">Ghada A Mohamed.</a> <a href="/aboulnourh/">Hassan Aboul-Nour حسن أبو النور</a>
Alex B. Chebl (@alexchebl) 's Twitter Profile Photo

ARAMIS Open label RCT DAPT vs tPA in Chinese minor stroke (NIHSS<6): median NIHSS 2. DAPT non-inferior with lower risk of deterioration and lower bleeding events. Higher NIHSS may be better w tPA. This is big deal #ISC23 Henry Ford Neuroscience Owais K. Alsrouji Ghada A Mohamed. Hassan Aboul-Nour حسن أبو النور

ARAMIS Open label RCT DAPT vs tPA in Chinese minor stroke (NIHSS&lt;6): median NIHSS 2. DAPT non-inferior with lower risk of deterioration and lower bleeding events. Higher NIHSS may be better w tPA. This is big deal #ISC23 <a href="/HenryFordNeuro/">Henry Ford Neuroscience</a> <a href="/OwaisAlsrouji/">Owais K. Alsrouji</a> <a href="/GhadaMohamedMD/">Ghada A Mohamed.</a> <a href="/aboulnourh/">Hassan Aboul-Nour حسن أبو النور</a>
Henry Ford Neuroscience (@henryfordneuro) 's Twitter Profile Photo

We are thrilled to welcome our new Chairman of Neurology, Dr. Brien J. Smith (Pictured here with Dr. Steven N. Kalkanis, Chairman, Henry Ford Medical Group). Read more about Dr. Smith here: henryford.com/news/2023/02/n… Steven N. Kalkanis MD Henry Ford Health

We are thrilled to welcome our new Chairman of Neurology, Dr. Brien J. Smith (Pictured here with Dr. Steven N. Kalkanis, Chairman, Henry Ford Medical Group). Read more about Dr. Smith here: henryford.com/news/2023/02/n… <a href="/SteveKalkanisMD/">Steven N. Kalkanis MD</a>  <a href="/HenryFordHealth/">Henry Ford Health</a>
Thanh Nguyen 🇺🇦 (@nguyenthanhmd) 's Twitter Profile Photo

A phase II randomized trial of Trendelenburg position for acute moderate ischemic stroke. nature.com/articles/s4146… led by Hui-Sheng Chen et al.

A phase II randomized trial of Trendelenburg position for acute moderate ischemic stroke.

nature.com/articles/s4146…  led by Hui-Sheng Chen et al.
Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

TIMELESS trial shows no benefit of TNK in the extended time window of 4.5-24 hours of LKW among patients with ICA/M1/M2 occlusion did not show benefit on the 90-day mRS without any signal of safety concerns. #ESOC2023

TIMELESS trial shows no benefit of TNK in the extended time window of 4.5-24 hours of LKW among patients with ICA/M1/M2 occlusion did not show benefit on the 90-day mRS without any signal of safety concerns. #ESOC2023
Shadi Yaghi (@shadiyaghi2) 's Twitter Profile Photo

Our latest in collaboration with Jim Siegler (@jimsieglermd.bsky.social now) Thanh Nguyen 🇺🇦 and co-authors. Acute basilar occlusions presenting with mild deficits based on NIHSS seem to do better with thrombectomy vs. medical treatment alone. ahajournals.org/doi/abs/10.116… Stroke AHA/ASA

Our latest in collaboration with <a href="/JimSiegler/">Jim Siegler (@jimsieglermd.bsky.social now)</a> <a href="/NguyenThanhMD/">Thanh Nguyen 🇺🇦</a> and co-authors.
Acute basilar occlusions presenting with mild deficits based on NIHSS seem to do better with thrombectomy vs. medical treatment alone.  ahajournals.org/doi/abs/10.116… <a href="/StrokeAHA_ASA/">Stroke AHA/ASA</a>
AshuJadhav (@ashupjadhav) 's Twitter Profile Photo

Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials - The Lancet thelancet.com/journals/lance…

AshuJadhav (@ashupjadhav) 's Twitter Profile Photo

Early Intubation in Endovascular Therapy for Basilar Artery Occlusion: A Post Hoc Analysis of the BASICS Trial | Stroke ahajournals.org/doi/10.1161/ST…

Early Intubation in Endovascular Therapy for Basilar Artery Occlusion: A Post Hoc Analysis of the BASICS Trial | Stroke ahajournals.org/doi/10.1161/ST…
Tudor G. Jovin, MD (@tudorgjovin) 's Twitter Profile Photo

Fantastic news for carotid stenosis patients who now have more treatment options based on their specific circumstances and personal preferences as CMS decided to cover CAS in non-high risk patients. However, CREST-2 enrollment remains as important as ever cms.gov/medicare-cover…

Henry Ford Neuroscience (@henryfordneuro) 's Twitter Profile Photo

Second Q&A with Drs. Entazami and Dr. Ramadan, again moderated by Dr. Alex B. Chebl. Thank you for your incredible insights on the limits of acute stroke care and the medical vs. surgical vs. endovascular management of the carotid web.

Second Q&amp;A with Drs. Entazami and Dr. Ramadan, again moderated by Dr. <a href="/AlexChebl/">Alex B. Chebl</a>. Thank you for your incredible insights on the limits of acute stroke care and the medical vs. surgical vs. endovascular management of the carotid web.
Alex B. Chebl (@alexchebl) 's Twitter Profile Photo

Amy Aho⁩ talking at 6th Detroit Stroke Conference about Navigating the Post-Stroke Journey, highlighting the Herculean effort and costs required by patients and their care givers in their recovery post stroke. A real hero! ⁦Henry Ford Neuroscience⁩ ⁦Riad Ramadan

⁦<a href="/AmyLynnAho/">Amy Aho</a>⁩ talking at 6th Detroit Stroke Conference about Navigating the Post-Stroke Journey, highlighting the Herculean effort and costs required by patients and their care givers in their recovery post stroke. A real hero! ⁦<a href="/HenryFordNeuro/">Henry Ford Neuroscience</a>⁩ ⁦<a href="/RiadRmdn/">Riad Ramadan</a>⁩
Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

#STROKE Topical Review by Andreas Charidimou MD, PhD & Eric_Smith_VCI: Cerebral microbleeds #CMBs in the setting of cerebral amyloid angiopathy #CAA: bleeding risk and safety of antithrombotic management. #AHAJournals ahajournals.org/doi/10.1161/ST…

#STROKE Topical Review by <a href="/a_charidimou/">Andreas Charidimou MD, PhD</a> &amp; <a href="/VCI_EricSmith/">Eric_Smith_VCI</a>: Cerebral microbleeds #CMBs in the setting of cerebral amyloid angiopathy #CAA: bleeding risk and safety of antithrombotic management. #AHAJournals ahajournals.org/doi/10.1161/ST…
Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

#STROKE Diagnostic Imaging: The CAROTID RING SIGN on single-phased #CTA is a potent imaging marker to differentiate true occlusion from pseudo-occlusion with sensitivity and specificity of 0.70 and 0.94, respectively. #AHAJournals ahajournals.org/doi/10.1161/ST… Yi Sui

#STROKE Diagnostic Imaging: The CAROTID RING SIGN on single-phased #CTA is a potent imaging marker to differentiate true occlusion from pseudo-occlusion with sensitivity and specificity of 0.70 and 0.94, respectively. #AHAJournals ahajournals.org/doi/10.1161/ST… <a href="/jake_sui/">Yi Sui</a>